In a pivotal moment for HIV prevention research, the Dr. Dawn K. Smith HIV Prevention Clinical Fellowship was announced at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI). This fellowship will provide an opportunity for U.S. licensed clinicians to gain hands-on training in HIV prevention strategies and mentorship from experienced educators within the field. Read more to find out additional details of the fellowship.
In a pivotal moment for HIV prevention research, the Dr. Dawn K. Smith HIV Prevention Clinical Fellowship was announced at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI). This fellowship, named in honor of the esteemed epidemiologist Dr. Dawn K. Smith, marks a significant stride forward in the ongoing battle against HIV/AIDS. Dr. Smith was at the forefront of PrEP research and her dedication to advancing evidence-based interventions and commitment to community engagement underscore the core principles of the fellowship.
One of the distinctive features of the Dr. Dawn K. Smith HIV Prevention Clinical Fellowship is its interdisciplinary approach. Recognizing the multifaceted nature of HIV prevention, the fellowship will welcome applicants from diverse backgrounds, including medicine, epidemiology, behavioral science, and public health. This interdisciplinary framework is designed to cultivate innovative thinking and foster collaboration across different fields, essential for tackling the complex challenges posed by HIV/AIDS.
Central to the fellowship experience is hands-on training in the implementation of cutting-edge HIV prevention strategies. Fellows will have the opportunity to engage in clinical research, community outreach initiatives, and policy advocacy efforts aimed at advancing HIV prevention at local, national, and global levels. Through mentorship from leading experts in the field, fellows will gain invaluable insights into the design, implementation, and evaluation of evidence-based interventions.
Moreover, the fellowship will prioritize addressing health disparities and promoting health equity in HIV prevention efforts. With a focus on vulnerable and marginalized populations disproportionately affected by HIV/AIDS, fellows will be encouraged to explore culturally competent approaches to prevention and care. By centering equity and inclusion, the fellowship seeks to reduce disparities in HIV incidence and ensure that all individuals have access to comprehensive prevention services.
In addition to its focus on research and practice, the Dr. Dawn K. Smith HIV Prevention Clinical Fellowship aims to cultivate leadership skills among its participants. Fellows will receive mentorship from experienced HIV clinicians and educators credentialed with The American Academy of HIV Medicine (AAHIVM) in strategic planning, advocacy, and community mobilization in hopes to empower them to become effective leaders in the field of HIV prevention.
By investing in the next generation of HIV prevention leaders, this fellowship adds to the commitment to innovation, collaboration, and equity for a future free of HIV/AIDS.
References
IDSE News Staff. New Fellowship to Improve HIV Prevention in Key Communities Available. Idse.net. March 2024. https://www.pharmacypracticenews.com/Online-First/Article/03-24/New-Fellowship-to-Improve-HIV-Prevention-in-Key-Communities-Available/73184
Dr. Dawn K. Smith HIV prevention clinical fellowship. American Academy of HIV Medicine. https://aahivm.org/dawn-k-smith-hiv-clinical-fellowship/